Abstract

Pooled estimates obtained in the first year of the COVID-19 pandemic suggest that 1 in 4 youth globally are experiencing clinically elevated depression symptoms, while 1 in 5 youth are experiencing clinically elevated anxiety symptoms. These pooled estimates, which increased over time, are double of prepandemic estimates. An influx of mental health care utilization is expected, and allocation of resources to address child and adolescent mental health concerns are essential.

Keywords

MedicineAnxietyPsycINFODepression (economics)Mental healthMEDLINEPsychiatryPrevalencePediatricsEpidemiologyInternal medicine

MeSH Terms

AdolescentAnxietyCOVID-19ChildDepressionGlobal HealthHumansPrevalence

Affiliated Institutions

Related Publications

Publication Info

Year
2021
Type
review
Volume
175
Issue
11
Pages
1142-1142
Citations
2462
Access
Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2462
OpenAlex
110
Influential
2031
CrossRef

Cite This

Nicole Racine, Brae Anne McArthur, Jessica E. Cooke et al. (2021). Global Prevalence of Depressive and Anxiety Symptoms in Children and Adolescents During COVID-19. JAMA Pediatrics , 175 (11) , 1142-1142. https://doi.org/10.1001/jamapediatrics.2021.2482

Identifiers

DOI
10.1001/jamapediatrics.2021.2482
PMID
34369987
PMCID
PMC8353576

Data Quality

Data completeness: 86%